These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18441312)

  • 1. Predicting response of vitreous hemorrhage after intravitreous injection of highly purified ovine hyaluronidase (Vitrase) in patients with diabetes.
    Bhavsar AR; Grillone LR; McNamara TR; Gow JA; Hochberg AM; Pearson RK;
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4219-25. PubMed ID: 18441312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pooled efficacy results from two multinational randomized controlled clinical trials of a single intravitreous injection of highly purified ovine hyaluronidase (Vitrase) for the management of vitreous hemorrhage.
    Kuppermann BD; Thomas EL; de Smet MD; Grillone LR;
    Am J Ophthalmol; 2005 Oct; 140(4):573-84. PubMed ID: 16125661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety results of two phase III trials of an intravitreous injection of highly purified ovine hyaluronidase (Vitrase) for the management of vitreous hemorrhage.
    Kuppermann BD; Thomas EL; de Smet MD; Grillone LR;
    Am J Ophthalmol; 2005 Oct; 140(4):585-97. PubMed ID: 16226510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronidase (Vitrase)--ISTA: hyaluronidase--ISTA pharmaceuticals.
    Drugs R D; 2003; 4(3):194-7. PubMed ID: 12757408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal triamcinolone acetonide injection at the end of vitrectomy for diabetic vitreous hemorrhage: a randomized, clinical trial.
    Faghihi H; Taheri A; Farahvash MS; Esfahani MR; Rajabi MT
    Retina; 2008 Oct; 28(9):1241-6. PubMed ID: 18626423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic vitreolysis with plasmin and hyaluronidase in diabetic rats.
    Zhi-Liang W; Wo-Dong S; Min L; Xiao-Ping B; Jin J
    Retina; 2009 Feb; 29(2):269-74. PubMed ID: 19050667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitrase ISTA Pharmaceuticals.
    Czajka M; Fekrat S
    IDrugs; 2002 Apr; 5(4):356-62. PubMed ID: 15565518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of microplasmin on the clearance of vitreous haemorrhage from an experimental model in rabbits.
    Gad Elkareem AM; de Smet MD
    Acta Ophthalmol; 2014 Feb; 92(1):47-50. PubMed ID: 23025384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyaluronidase as a liquefying agent for chemical analysis of vitreous fluid.
    Garg U; Althahabi R; Amirahmadi V; Brod M; Blanchard C; Young T
    J Forensic Sci; 2004 Mar; 49(2):388-91. PubMed ID: 15027566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of hyaluronidase 75 IU as an adjuvant to mepivacaine for retrobulbar anesthesia in cataract surgery.
    Remy M; Pinter F; Nentwich MM; Kampik A; Schönfeld CL
    J Cataract Refract Surg; 2008 Nov; 34(11):1966-9. PubMed ID: 19006746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical manifestations and treatment of Terson's syndrome].
    Prost ME
    Klin Oczna; 1996; 98(5):371-4. PubMed ID: 9213597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new Modified Intracerebral Hemorrhage score for treatment decisions in basal ganglia hemorrhage--a randomized trial.
    Cho DY; Chen CC; Lee WY; Lee HC; Ho LH
    Crit Care Med; 2008 Jul; 36(7):2151-6. PubMed ID: 18552701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy.
    Wang X; Wang G; Wang Y
    Am J Ophthalmol; 2009 Dec; 148(6):883-9. PubMed ID: 19837381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular biology of pharmacologic vitreolysis.
    Sebag J
    Trans Am Ophthalmol Soc; 2005; 103():473-94. PubMed ID: 17057814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective study of in-office diagnostic vitreous sampling in patients with vitreoretinal pathology.
    Pfahler SM; Brandford AN; Glaser BM
    Retina; 2009; 29(7):1032-5. PubMed ID: 19373124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment and implication of the allergic sensitivity to a single dose of recombinant human hyaluronidase injection: a double-blind, placebo-controlled clinical trial.
    Yocum RC; Kennard D; Heiner LS
    J Infus Nurs; 2007; 30(5):293-9. PubMed ID: 17895809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of the safety and efficacy of preservative-free triamcinolone (triesence [triamcinolone acetonide injectable suspension] 40 mg/ml) for visualization during pars plana vitrectomy.
    Dyer D; Callanan D; Bochow T; Abraham P; Lambert HM; Lee SY; Schneiderman T; Potts SL; Walker TM
    Retina; 2009 Jan; 29(1):38-45. PubMed ID: 18827733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal gas injection for the treatment of experimental vitreous hemorrhage in rabbits.
    Mello-Filho PA; Cardillo JA; Farah ME; Morales PH; Mitre J; Magalhães O; Paranhos A; Costa RA
    Curr Eye Res; 2002 Nov; 25(5):261-5. PubMed ID: 12658544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angioedema after ovine hyaluronidase injection for treating hyaluronic acid overcorrection.
    Andre P; Fléchet ML
    J Cosmet Dermatol; 2008 Jun; 7(2):136-8. PubMed ID: 18482018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
    Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
    J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.